BENIGN PROSTATIC HYPERPLASIA (THE AGING PROSTATE)
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 83 (5) , 1213-1229
- https://doi.org/10.1016/s0025-7125(05)70159-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive PatientsJournal of Urology, 1997
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experienceUrology, 1995
- Symptoms and signs of prostatism as risk factors for prostatectomyThe Prostate, 1990
- Urodynamics in benign prostatic hyperplasia: A surveyThe Prostate, 1989
- Phenoxybenzamine for benign prostatic obstruction review of 200 casesUrology, 1981
- Natural history of benign prostatic hypertrophy and acute urinary retentionUrology, 1976